Glioblastoma-secreted soluble CD44 activates tau pathology in the brain

Area of Science:

• Neuroscience
• Oncology
• Biochemistry

Background:

• Glioblastoma cells secrete molecules affecting the brain.
• The brain's biochemical response to glioblastoma is not well understood.

Purpose of the Study:

• To investigate the neurodegenerative effects of the glioblastoma secretome.
• To identify specific molecules responsible for glioblastoma-induced neurodegeneration.

Main Methods:

• Analysis of glioblastoma-xenograft tissues.
• Secretome analysis to identify key proteins.
• In vitro treatment of hippocampal neurons with soluble CD44 (sCD44).
• In vivo injection of sCD44 into tau transgenic mice.

Main Results:

• Glioblastoma tissues showed degenerating neurons with phosphorylated tau.
• Soluble CD44 was identified as the protein inducing tau phosphorylation and aggregation.
• sCD44 treatment caused tau hyperphosphorylation and neuronal degeneration in primary neurons and mouse models.

Conclusions:

• Soluble CD44 secreted by glioblastoma promotes tau pathology.
• sCD44 acts as a molecular link between glioblastoma and neurodegeneration.
• Targeting sCD44 may offer therapeutic strategies for glioblastoma-associated neurodegeneration.